SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector, pCDH-CMV-SARS-CoV-2-N-EF1alpha-Puro (Pre-packaged Lentivirus)

Product Description

Streamline your COVID-19 studies with constructs expressing the SARS-CoV-2 nucelocapsid protein (N protein) – based on SBI’s robust lentivector technology

• Leverage SBI’s robust lentivector expression technology to study the SARS-CoV-2 nucleocapsid protein
• Choose ready-to-package plasmid or ready-to-transduce virus
• Additional SARS-CoV-2 expression constructs also available

SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector delivers SARS-CoV-2 N protein expression from the CMV promoter with a separate EF1α promoter driving the expression of the puromycin resistance gene for selection. Available in both plasmid and pre-packaged lentivirus formats, the SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector enables a wide range of studies using the systems of your choice.